Pages
Home
Our Purpose
Leadership
Other Links
Sunday, December 12, 2010
Study Of Novartis Drug Zometa For Potential New Use In Early Breast Cancer Did Not Meet Primary Endpoint In Overall Study Population
Study Of Novartis Drug Zometa For Potential New Use In Early Breast Cancer Did Not Meet Primary Endpoint In Overall Study Population
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment